| Gary John Palmer, MD | |
|
7073 Clyo Rd, Centerville, OH 45459-4816 | |
| (937) 435-5857 | |
| (937) 912-4960 |
| Full Name | Gary John Palmer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 26 Years |
| Location | 7073 Clyo Rd, Centerville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053316893 | NPI | - | NPPES |
| 2243709 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35-07-7315-P (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Queen City Skilled Care Llc | Cincinnati, OH | Home health agency |
| Hospice Of Dayton | Dayton, OH | Hospice |
| Heartland Home Health Care & Hospice | Kettering, OH | Hospice |
| Hospice Of The Miami Valley | Xenia, OH | Hospice |
| Promedica Skilled Nursing & Rehab Centerville | Centerville, OH | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohio Post-acute Medical Services 1 Inc | 5991081911 | 8 |
News Archive
Panic buying and the hoarding of face masks to protect from the coronavirus disease (COVID-19) may not be a good idea, says a health expert. It puts you at an increased risk of contracting the virus.
Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
New research by a University of Georgia scientist reveals that girls who are maltreated show higher levels of inflammation at an early age than boys who are maltreated or children who have not experienced abuse. This finding may forecast chronic mental and physical health problems in midlife.
› Verified 1 days ago
| Entity Name | Inpatient Consultants Of Ohio, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326210121 PECOS PAC ID: 0749357887 Enrollment ID: O20080916000198 |
News Archive
Panic buying and the hoarding of face masks to protect from the coronavirus disease (COVID-19) may not be a good idea, says a health expert. It puts you at an increased risk of contracting the virus.
Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
New research by a University of Georgia scientist reveals that girls who are maltreated show higher levels of inflammation at an early age than boys who are maltreated or children who have not experienced abuse. This finding may forecast chronic mental and physical health problems in midlife.
› Verified 1 days ago
| Entity Name | Ohio Post-acute Medical Services 1 Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215475199 PECOS PAC ID: 5991081911 Enrollment ID: O20170405002175 |
News Archive
Panic buying and the hoarding of face masks to protect from the coronavirus disease (COVID-19) may not be a good idea, says a health expert. It puts you at an increased risk of contracting the virus.
Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
New research by a University of Georgia scientist reveals that girls who are maltreated show higher levels of inflammation at an early age than boys who are maltreated or children who have not experienced abuse. This finding may forecast chronic mental and physical health problems in midlife.
› Verified 1 days ago
| Entity Name | Nv Pacs 2 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427534809 PECOS PAC ID: 0941550578 Enrollment ID: O20210806002167 |
News Archive
Panic buying and the hoarding of face masks to protect from the coronavirus disease (COVID-19) may not be a good idea, says a health expert. It puts you at an increased risk of contracting the virus.
Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
New research by a University of Georgia scientist reveals that girls who are maltreated show higher levels of inflammation at an early age than boys who are maltreated or children who have not experienced abuse. This finding may forecast chronic mental and physical health problems in midlife.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gary John Palmer, MD 36115 Schoolcraft Rd, Livonia, MI 48150-1216 Ph: (734) 464-0887 | Gary John Palmer, MD 7073 Clyo Rd, Centerville, OH 45459-4816 Ph: (937) 435-5857 |
News Archive
Panic buying and the hoarding of face masks to protect from the coronavirus disease (COVID-19) may not be a good idea, says a health expert. It puts you at an increased risk of contracting the virus.
Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
New research by a University of Georgia scientist reveals that girls who are maltreated show higher levels of inflammation at an early age than boys who are maltreated or children who have not experienced abuse. This finding may forecast chronic mental and physical health problems in midlife.
› Verified 1 days ago
Shahila Navayogarajah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7457 Pelbrook Farm Dr, Centerville, OH 45459 Phone: 937-435-4643 | |
Dr. Kavitha Aluri Choudary, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7073 Clyo Rd, Centerville, OH 45459 Phone: 937-435-5857 Fax: 937-912-4960 | |
Dr. Sarah M Hedrick, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6661 Clyo Rd, Centerville, OH 45459 Phone: 937-425-4000 Fax: 937-425-4002 | |
Dr. Jhansi L Koduri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Miami Valley Dr Ste 150, Centerville, OH 45459 Phone: 937-293-1622 Fax: 937-245-6308 | |
Dr. William Earl Venanzi Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1989 Miamisburg Centerville Rd Ste 301, Centerville, OH 45459 Phone: 937-434-7353 Fax: 937-438-6569 | |
Gary J Fishbein, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2350 Miami Valley Dr Ste 310, Centerville, OH 45459 Phone: 937-277-4274 Fax: 937-277-8476 |